Epithelial expression and release of FGF-2 from heparan sulphate binding sites in bronchial tissue in asthma

Shute, J. K.; Solic, N.; Shimizu, J.; McConnell, W.; Reclington, A. E.; Howarth, P. H.
July 2004
Thorax;Jul2004, Vol. 59 Issue 7, p557
Academic Journal
Background: The most characteristic structural change evident in endobronchial biopsies in asthma, even in mild disease, is subepithelial collagen deposition within the lamina reticularis. This has been associated with progressive loss of lung function and the persistence of airway hyperresponsiveness, and has been linked to airway fibroblast proliferation. A potent fibroproliferative factor in bronchoalveolar lavage Huid in asthma is fibroblast growth factor-2 (FGF-2). FGF-2 is a member of a family of heparin binding growth factors that bind to heparan sulphate proteoglycans (HSPG), an important determinant of FGF-2 activity. This study compared the level of expression and distribution of FGF-2 in relation to HSPG in bronchial tissue from normal and asthmatic subjects. Methods: The distribution of FGF-2 and HSPG in intact and cleaved forms in endobronchial biopsies from normal and asthmatic subjects was examined using an immunohistochemical approach. A novel ELISA based method was developed to detect solubilisation of FGF-2 following addition of heparin and heparitinose to bronchial tissue slices. Results: Immunohistochemical analysis showed that FGF-2 was co-localised to HSPG in epithelial and endothelial basement membranes. Epithelial FGF-2, but not HSPG, was significantly more abundant in patients with mild asthma than in normal sublects. In vitro experiments indicated that FGF-2 was released from binding sites in the tissue by heparin and heparitinase I. Conclusions: FGF-2 is bound by HSPG in bronchial tissue. The mast cell, through the release of heparin and endoglycosidase, may make a unique contribution to tissue remodelling in allergic asthma.


Related Articles

  • Airway Epithelial Cell Release of Cytokines: Modulation by Various Therapeutic Agents. Frieri, Marianne // Allergy & Asthma Proceedings;Nov/Dec2004, Vol. 25 Issue 6, p387 

    The airway epithelial cell plays a central role in asthma pathogenesis and potential remodeling in secreting numerous cytokines, growth factors, chemokines, and nitric oxide. The role of various therapeutic agents on in vivo and in vitro antigen, growth factor, and respiratory syncytial...

  • Symposium: Inflammatory Issues in Allergic Rhinitis and Asthma. Frieri, Marianne // Allergy & Asthma Proceedings;May/Jun2005, Vol. 26 Issue 3, p163 

    Allergic rhinitis and asthma are both systemic inflammatory disorders with similar pathophysiological mechanisms involving numerous cells and inflammatory mediators. Some airway remodeling also might exist in allergic rhinitis. This review has summarized selected investigative studies from our...

  • VIRUSES AND THE LUNG: PATHOGEN OR PASSENGERS.  // Thorax;Dec2001 Supp, Vol. 56, piii14 

    This article presents various studies which explore effects of viruses on lungs. Rhinoviruses (RV) are important respiratory pathogens causing the majority of common colds, and are associated with exacerbations of asthma and COPD. Low dose Rhinovirus infection produces increase in cytokine...

  • Location location, location: microlocalisation of inflammatory cells and airways dysfunction. Brightling, C. E.; Pavord, I. D. // Thorax;Sep2004, Vol. 59 Issue 9, p734 

    The article focuses on the role of microlocalisation of inflammatory and structural cells in the pathogenesis of asthma, chronic obstructive pulmonary diseases (COPD) and cough. Activation of the inflammatory cells within the airway smooth muscle bundle would be predicted to have important...

  • Airway Smooth Muscle: Immunomodulatory Cells? Panettieri, Jr., Reynold A. // Allergy & Asthma Proceedings;Nov/Dec2004, Vol. 25 Issue 6, p381 

    Evidence suggests that airway smooth muscle, the most important cell modulating bronchomotor tone, plays an important immunomodulatory role in the orchestration and perpetuation of airway inflammation. The signaling pathways that modulate leukocyte function may be disparate from those found in...

  • 47 Year Old Patient with Pseudo-Asthma. Altinsoy, Bulent; Altinta, Nejat; Celik, Zeynep Sonmez // Oman Medical Journal;Jan2011, Vol. 26 Issue 1, p61 

    A quiz concerning the occurrence of pseudo-asthma is presented.

  • Self-management education for patients with chronic obstructive pulmonary disease: a systematic review. Monninkhof, E.; van der Valk, P.; van der Palen, J.; van Herwaarden, C.; Partidge, M.R.; Zielhuis, G. // Thorax;May2003, Vol. 58 Issue 5, p394 

    Background: The idea of self-management is to teach patients how to carry out the activities of daily living optimally in the face of their physiological impairment, and to prevent or decrease the severity of exacerbations by means of life style adaptation. In chronic obstructive pulmonary...

  • Inadequate peak expiratory flow meter characteristics detected by a computerised explosive decompression device. Miller, M.R.; Atkins, P.R.; Pedersen, O.F. // Thorax;May2003, Vol. 58 Issue 5, p411 

    Background: Recent evidence suggests that the frequency response requirements for peak expiratory flow (PEF) meters are higher than was first thought and that the American Thoracic Society (ATS) waveforms to test PEF meters may not be adequate for the purpose. Methods: The dynamic response of...

  • Telephone 'asthma clinics'? Hurst, J. // Thorax;May2003, Vol. 58 Issue 5, p457 

    Looks at the telephone consultation as a means of improving asthma review rates. Identification of adult asthmatic patients who consented to participate and were randomized to telephone or standard face to face review; Analysis of asthma morbidity, patient satisfaction and consultation duration.


Read the Article


Sorry, but this item is not currently available from your library.

Try another library?
Sign out of this library

Other Topics